Circassia Pharmaceuticals Plc (CIR) - Financial and Strategic SWOT Analysis Review

  • ID: 4284731
  • SWOT Analysis
  • 41 pages
  • GlobalData
  • Circassia Pharmaceuticals
1 of 5

FEATURED COMPANIES

  • Clinigen Group Plc
  • GlaxoSmithKline Plc
  • Oxagen Ltd
  • Synairgen Plc
  • Verona Pharma Plc
  • MORE
Cir cassia Pharmaceuticals Plc (CIR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Cir cassia Pharmaceuticals plc (Cir cassia) develops and manufactures drugs for the treatment of allergy and respiratory diseases such as asthma. The company’s marketed products include Nix used to assist asthma management and Tudor for the treatment of chronic obstructive pulmonary disease. The company had several inhaled medicines in pipeline intended for the treatment chronic obstructive pulmonary disease (COPD), which include single and combination dose products. The company offers its products to COPD and asthma specialists in the US, the UK, Germany and other countries through its network of partners. Cir cassia is headquartered in Oxford, England, the UK.

Cir cassia Pharmaceuticals Plc Key Recent Developments

Apr 24, 2018: Cir cassia Pharmaceuticals: Preliminary Results for the Year Ended 31 December 2017
Feb 13, 2018: Cir cassia Announces Changes to its Board of Directors
Nov 29, 2017: Cir cassia Welcomes New NICE Guidelines Recommending Use of FeNO Testing in Asthma Diagnosis
Sep 27, 2017: Cir cassia Pharmaceuticals: Interim Results for the Six Months Ended 30 June 2017
Apr 25, 2017: Cir cassia Pharmaceuticals: Preliminary Results for the Year Ended 31 December 2016

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Clinigen Group Plc
  • GlaxoSmithKline Plc
  • Oxagen Ltd
  • Synairgen Plc
  • Verona Pharma Plc
  • MORE
Section 1 - About the Company
Circassia Pharmaceuticals Plc - Key Facts
Circassia Pharmaceuticals Plc - Key Employees
Circassia Pharmaceuticals Plc - Key Employee Biographies
Circassia Pharmaceuticals Plc - Major Products and Services
Circassia Pharmaceuticals Plc - History
Circassia Pharmaceuticals Plc - Company Statement
Circassia Pharmaceuticals Plc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis
Company Overview
Circassia Pharmaceuticals Plc - Business Description
Business Segment: Niox Segment
Overview
Performance
Business Segment: Respiratory segment
Overview
Performance
Business Segment: US AZ collaboration
Overview
Performance
Geographical Segment: Asia Pacific
Performance
Geographical Segment: EU
Performance
Geographical Segment: Rest of World
Performance
Geographical Segment: US
Performance
R&D Overview
Circassia Pharmaceuticals Plc - SWOT Analysis
SWOT Analysis - Overview
Circassia Pharmaceuticals Plc - Strengths
Circassia Pharmaceuticals Plc - Weaknesses
Circassia Pharmaceuticals Plc - Opportunities
Circassia Pharmaceuticals Plc - Threats
Circassia Pharmaceuticals Plc - Key Competitors

Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

Section 4 – Company’s Lifesciences Financial Deals and Alliances
Circassia Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Circassia Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Circassia Pharmaceuticals Plc, Recent Deals Summary

Section 5 – Company’s Recent Developments
Apr 24, 2018: Circassia Pharmaceuticals: Preliminary Results for the Year Ended 31 December 2017
Feb 13, 2018: Circassia Announces Changes to its Board of Directors
Nov 29, 2017: Circassia Welcomes New NICE Guidelines Recommending Use of FeNO Testing in Asthma Diagnosis
Sep 27, 2017: Circassia Pharmaceuticals: Interim Results for the Six Months Ended 30 June 2017
Apr 25, 2017: Circassia Pharmaceuticals: Preliminary Results for the Year Ended 31 December 2016
Apr 25, 2017: Circassia Announces Non-Executive Director Retirements

Section 6 – Appendix
Methodology
Ratio Definitions
About
Contact Us
Disclaimer

List of Tables
Circassia Pharmaceuticals Plc, Key Facts
Circassia Pharmaceuticals Plc, Key Employees
Circassia Pharmaceuticals Plc, Key Employee Biographies
Circassia Pharmaceuticals Plc, Major Products and Services
Circassia Pharmaceuticals Plc, History
Circassia Pharmaceuticals Plc, Subsidiaries
Circassia Pharmaceuticals Plc, Key Competitors
Circassia Pharmaceuticals Plc, Ratios based on current share price
Circassia Pharmaceuticals Plc, Annual Ratios
Circassia Pharmaceuticals Plc, Interim Ratios
Circassia Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Circassia Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Circassia Pharmaceuticals Plc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Circassia Pharmaceuticals Plc, Performance Chart (2013 - 2017)
Circassia Pharmaceuticals Plc, Ratio Charts
Circassia Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Circassia Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Verona Pharma Plc
  • Synairgen Plc
  • Oxagen Ltd
  • GlaxoSmithKline Plc
  • Clinigen Group Plc
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll